outlined that SARS-CoV-2 infection disrupts mTOR signaling and suggested that its inhibition could be a powerful tool for immune response regulation in COVID-19, a conclusion supported by Abu-Eid et al. The gene discussed is MTOR; the disease is COVID-19.